834. Characterization of Heavily Treatment Experienced HIV-1 Infected Clinical Trial Participants Infected with SARS-CoV-2 COVID 19: Fostemsavir BRIGHTE Phase 3 Clinical Trial

por Chabria, Shiven, De Wit, Stephane, Pierce, Amy, Shepherd, Bronagh M, Warwick-Sanders, Michael, Du, Fangfang, Wang, Marcia, Clark, Andrew, Ackerman, Peter
Publicado 2021